Raia Drogasil Sa Stock Working Capital
| RADLY Stock | USD 4.42 0.27 6.51% |
Raia Drogasil SA fundamentals help investors to digest information that contributes to Raia Drogasil's financial success or failures. It also enables traders to predict the movement of Raia Pink Sheet. The fundamental analysis module provides a way to measure Raia Drogasil's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Raia Drogasil pink sheet.
Raia |
Raia Drogasil SA Company Working Capital Analysis
Raia Drogasil's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Based on the company's disclosures, Raia Drogasil SA has a Working Capital of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Pharmaceutical Retailers (which currently averages 0.0) industry. The working capital for all United States stocks is 100.0% higher than that of the company.
Raia Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Raia Drogasil's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Raia Drogasil could also be used in its relative valuation, which is a method of valuing Raia Drogasil by comparing valuation metrics of similar companies.Raia Drogasil is currently under evaluation in working capital category among its peers.
Raia Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0667 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 8.48 B | |||
| Shares Outstanding | 1.65 B | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Earning | 80.00 X | |||
| Price To Book | 7.21 X | |||
| Price To Sales | 0.26 X | |||
| Revenue | 24.13 B | |||
| Gross Profit | 7.21 B | |||
| EBITDA | 2.54 B | |||
| Net Income | 751.93 M | |||
| Cash And Equivalents | 818.81 M | |||
| Cash Per Share | 0.50 X | |||
| Total Debt | 891.39 M | |||
| Debt To Equity | 1.21 % | |||
| Current Ratio | 1.57 X | |||
| Book Value Per Share | 3.07 X | |||
| Cash Flow From Operations | 1.55 B | |||
| Earnings Per Share | 0.10 X | |||
| Number Of Employees | 51.48 K | |||
| Beta | 0.35 | |||
| Market Capitalization | 20.08 B | |||
| Total Asset | 14.78 B | |||
| Z Score | 14.2 | |||
| Annual Yield | 0 % | |||
| Net Asset | 14.78 B | |||
| Last Dividend Paid | 0.055 |
About Raia Drogasil Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Raia Drogasil SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Raia Drogasil using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Raia Drogasil SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Raia Pink Sheet Analysis
When running Raia Drogasil's price analysis, check to measure Raia Drogasil's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raia Drogasil is operating at the current time. Most of Raia Drogasil's value examination focuses on studying past and present price action to predict the probability of Raia Drogasil's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raia Drogasil's price. Additionally, you may evaluate how the addition of Raia Drogasil to your portfolios can decrease your overall portfolio volatility.